EFEarnings Feed

Filing detail

6-KTicker ENLVCIK 0001596812

Enlivex Therapeutics Ltd. 6-K

Accession 0001213900-25-110920

Filed Nov 13, 7:00 PM ETAccepted Nov 14, 4:30 PM ETSize 408.9 KB
View on sec.gov ↗Open company profile

Filed (ET)

Nov 13, 7:00 PM ET

Accepted

Nov 14, 4:30 PM ET

File size

408.9 KB

SEC accession

0001213900-25-110920

Filing details

Company
Enlivex Therapeutics Ltd.
CIK
0001596812
Incorporated
Israel
Entity type
other

Related parties

  • filerCIK 0001596812

Documents

Attached files
3 items

  • ea0265573-6k_enlivex.htm

    6-K

    REPORT OF FOREIGN PRIVATE ISSUER

    PrimaryOpen file ↗

  • ea026557301ex99-1_enlivex.htm

    EX-99.1

    UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR ENLIVEX AS OF SEPTEMBER 30, 2025 AND DECEMBER 31, 2024 AND FOR THE THREE AND NINE MONTH PERIODS ENDED SEPTEMBER 30, 2025 AND 2024

    Open file ↗

  • ea026557301ex99-2_enlivex.htm

    EX-99.2

    OPERATING AND FINANCIAL REVIEW AND PROSPECTS AS OF AND FOR THE THREE AND NINE MONTH PERIODS ENDED SEPTEMBER 30, 2025 AND 2024

    Open file ↗